Clinical Trials Directory

Trials / Unknown

UnknownNCT05692856

Muscle Memory After Treatment With Anabolic Substance Clenbuterol and Resistance Training in Humans

Muscle Memory After Treatment With Anabolic Substance Clenbuterol and Resistance Training in Humans: Myonuclear Addition, Hypertrophy and Myocellular Reprogramming

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Morten Hostrup, PhD · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of the project is investigate muscle memory and underlying mechanisms in humans following resistance training and use of the anabolic substance clenbuterol.

Conditions

Interventions

TypeNameDescription
DRUGClenbuterolParticipants ingest 80 micrograms clenbuterol daily during the initial 8-week period. This period is followed by a washout of 16 weeks with no drug and resistance training. Thereafter, an 8-week period with supervised resistance training is commenced, with no drug.
DRUGPlaceboParticipants ingest placebo tablets daily during the initial 8-week period. This period is followed by a washout of 16 weeks with no drug and resistance training. Thereafter, an 8-week period with supervised resistance training is commenced, with no drug.

Timeline

Start date
2023-02-01
Primary completion
2024-12-01
Completion
2025-08-01
First posted
2023-01-20
Last updated
2023-01-20

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT05692856. Inclusion in this directory is not an endorsement.